WuXi Biologics (Cayman) Inc.
2269
Kedudukan dalam Saham
#991
Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman)... Headquartered in Wuxi, China, and established in 2014, WuXi Biologics (Cayman) Inc. delivers a comprehensive, integrated suite of services spanning the entire biologics lifecycle, from initial discovery through development to large-scale manufacturing. The company's operations have a global footprint, serving clients across the People's Republic of China, North America, Europe, and other international regions. Its diversified offerings also include specialized consultation in biopharmaceutical technology, international sales contracting, the development and deployment of advanced testing methodologies, and robust marketing and sales support. Furthermore, WuXi Biologics is involved in providing dedicated biologics clinical and manufacturing services, the production and distribution of various medical products, contract development and manufacturing (CDMO) for vaccines and associated businesses, and acting as a supplier of key materials. The firm maintains strategic partnerships with notable entities such as ImmuneOncia Therapeutics, Legochem Biosciences Inc., Worg Pharma, OncoC4, and Exelixis Inc.
Harga Saham
$5.73
Modal Pasaran
$23.57B
Perubahan (1 hari)
-9.03%
Perubahan (1 tahun)
24.25%
Negara
CN
Perdagangan WuXi Biologics (Cayman) Inc. (2269)
Kategori
Healthcare
Bilangan saham terbitan bagi WuXi Biologics (Cayman) Inc. (2269)
Bilangan saham terbitan setakat October 2026: 0
Menurut laporan kewangan terkini dan harga saham WuXi Biologics (Cayman) Inc., bilangan saham terbitan semasa ialah 0. Pada akhir October 2026, syarikat mempunyai 0 saham terbitan. Bilangan saham terbitan biasanya dipengaruhi oleh pecahan saham dan pembelian balik saham.
Sejarah saham terbitan untuk WuXi Biologics (Cayman) Inc. (2269) dari 2014 hingga 2026
Saham terbitan pada akhir setiap tahun
| Tahun | Saham Terbitan | Ubah |
|---|---|---|
| 2025 | 4.18B | 2.29% |
| 2024 | 4.08B | -1.96% |
| 2023 | 4.16B | -0.22% |
| 2022 | 4.17B | -5.18% |
| 2021 | 4.40B | 4.55% |
| 2020 | 4.21B | 5.30% |
| 2019 | 4.00B | 1.42% |
| 2018 | 3.94B | 22.31% |
| 2017 | 3.22B | -5.29% |
| 2016 | 3.40B | 0.00% |
| 2015 | 3.40B | 0.00% |
| 2014 | 3.40B | 0.00% |
Saham terbitan bagi syarikat atau pesaing yang serupa
| Syarikat | Saham Terbitan | Perbezaan | Negara |
|---|---|---|---|
| 253.90M | - |
US
|
|
| 396.00M | - |
US
|
|
| 478.91M | - |
AU
|
|
| 62.19M | - |
NL
|
|
| - | - |
CH
|
